PHARMACISTS’ KNOWLEDGE AND ATTITUDES ABOUT ADRS REPORTING AND PHARMACOVIGILANCE PRACTICE IN EGYPTIAN HOSPITALS”
Tolba, M., Abdel-Latif, M., Hassan, S. (2022). PHARMACISTS’ KNOWLEDGE AND ATTITUDES ABOUT ADRS REPORTING AND PHARMACOVIGILANCE PRACTICE IN EGYPTIAN HOSPITALS”. EKB Journal Management System, 45(2), 869-882. doi: 10.21608/bfsa.2022.271688
Marwa Kamal Tolba; Mohamed Mahmoud Abdel-Latif; Sahar Badr Hassan. "PHARMACISTS’ KNOWLEDGE AND ATTITUDES ABOUT ADRS REPORTING AND PHARMACOVIGILANCE PRACTICE IN EGYPTIAN HOSPITALS”". EKB Journal Management System, 45, 2, 2022, 869-882. doi: 10.21608/bfsa.2022.271688
Tolba, M., Abdel-Latif, M., Hassan, S. (2022). 'PHARMACISTS’ KNOWLEDGE AND ATTITUDES ABOUT ADRS REPORTING AND PHARMACOVIGILANCE PRACTICE IN EGYPTIAN HOSPITALS”', EKB Journal Management System, 45(2), pp. 869-882. doi: 10.21608/bfsa.2022.271688
Tolba, M., Abdel-Latif, M., Hassan, S. PHARMACISTS’ KNOWLEDGE AND ATTITUDES ABOUT ADRS REPORTING AND PHARMACOVIGILANCE PRACTICE IN EGYPTIAN HOSPITALS”. EKB Journal Management System, 2022; 45(2): 869-882. doi: 10.21608/bfsa.2022.271688

PHARMACISTS’ KNOWLEDGE AND ATTITUDES ABOUT ADRS REPORTING AND PHARMACOVIGILANCE PRACTICE IN EGYPTIAN HOSPITALS”

Bulletin of Pharmaceutical Sciences Assiut University
Volume 45, Issue 2, December 2022, Page 869-882  XML PDF (1012.79 K)
Document Type: Original Article
DOI: 10.21608/bfsa.2022.271688
View on SCiNiTO View on SCiNiTO
Authors
Marwa Kamal Tolba email orcid 1; Mohamed Mahmoud Abdel-Latif email 2; Sahar Badr Hassan email 2
1Clinical pharmacy department, faculty of pharmacy, fayoum universit, fayoum, egypt
2Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt
Abstract
Background: Pharmacovigilance is the practice of discovering and reducing risks associated with pharmaceutical products, as well as improving patient safety by evaluating the risk-benefit ratio of medications. The current study looked at pharmacists' knowledge, attitudes, and practices regarding ADR reporting, as well as the factors that may influence reporting. Methods: A cross-sectional questionnaire-based survey was conducted to collect data from 258 pharmacists from May 2020 to September 2021. A pre-designed questionnaires evaluating knowledge, attitude and practice were distributed and filled questionnaires were collected and analyzed. Results: More than third of pharmacists were unsure to whom ADRs reports should be reported , and about 26.36% said ADRs should be reported to the national ADR monitoring center. More than third group of pharmacists (34.11%) said that pharmacists are responsible for reporting ADRs, while (65.89%) said that all healthcare providers should report ADRs. Conclusions: Most pharmacists had sufficient knowledge of pharmacovigilance and maintained a positive attitude towards ADRs reporting. Education and training of ADRs reporting can be used as one of the planning strategies to improve the reporting rate. This trial is registered with ClinicalTrial.gov, number NCT05224804.
Keywords
pharmacists; knowledge; adverse drug reactions; reporting; pharmacovigilance
Statistics
Article View: 148
PDF Download: 179